Steven Pfanstiel, CFO AND COO at MARINUS PHARMACEUTICALS, INC. (MRNS), sold 3,092 shares at $9.97 ($31K) on 2024-02-16, disclosed to the SEC on 2024-02-21.
Scheduled sale ($31k) by CFO AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRNS | SELL | 2024-08-07 | $5K | — | Filing → |
| MRNS | SELL | 2023-08-08 | $27K | — | Filing → |